Systems Based Neurotechnology for Emerging Therapies (SUBNETS) | Apply Online

Frequently Asked Questions (FAQs)

What is the SUBNETS program?

Systems Based Neurotechnology for Emerging Therapies (SUBNETS) is a DARPA Defense Sciences Office research program focused on developing a practical, science-backed path to treat complex brain disorders by understanding them as systems-level (network) problems rather than isolated defects.

What core idea is SUBNETS based on?

The program is built on the idea that many neuropsychiatric and neurologic conditions come from dysfunctional activity across multiple interacting brain circuits (subnetworks). SUBNETS aims to improve treatment by creating technologies that can measure these circuits in real time, interpret what the signals mean, and deliver precisely targeted stimulation to guide the brain back toward healthier function.

What kinds of conditions is SUBNETS trying to address?

The opportunity broadly targets neuropsychiatric and neurologic disorders that involve disrupted brain networks. It particularly emphasizes helping people who do not respond well to existing therapies, including veterans and active duty service members facing serious mental health and neurological challenges.

What does "systems-based" mean in the context of this program?

In this program, "systems-based" refers to treating brain disorders as problems that emerge from interactions among multiple circuits (subnetworks). Rather than focusing on a single brain area or a single defect, SUBNETS emphasizes understanding and influencing the dynamic behavior of connected neural circuits.

What is "closed-loop therapy" as described in SUBNETS?

Closed-loop therapy refers to an approach where a system continuously records neural activity, detects patterns linked to symptoms or disease states, and automatically adjusts stimulation in response. This differs from stimulation delivered on a fixed schedule or adjusted only occasionally.

How is closed-loop therapy different from traditional stimulation approaches?

Traditional stimulation approaches often use fixed schedules or parameters that are adjusted infrequently. SUBNETS emphasizes continuous monitoring and automatic, real-time adjustment of stimulation based on detected neural patterns associated with symptoms or disease states.

What is meant by "precision therapy" in SUBNETS?

In SUBNETS, "precision therapy" means tailoring intervention to an individual’s brain dynamics and enabling the therapy to adapt as those dynamics change over time. The concept depends on integrating sensing (recording), interpretation (analytics/models), and action (stimulation) into a responsive system.

What technical components does SUBNETS envision for a closed-loop system?

The program description points to combining neural recording (to observe activity) with neural stimulation (to modify activity), supported by computational and physiological models that translate raw neural signals into clinically meaningful control strategies.

Is SUBNETS focused on one disorder or multiple disorders?

SUBNETS reflects DARPA’s interest in platform technology rather than a one-off solution for a single disorder. While disease treatment is a major motivation, the intended deliverable is a set of generalizable tools and methods that could be applied across multiple illnesses involving disrupted brain networks.

What types of deliverables or capabilities does the program aim to produce?

The opportunity emphasizes an integrated set of tools, including novel neurotechnology hardware, modeling and analytics that can work with complex human neural data during behavior, and translational approaches connecting animal research, clinical neurology, and human device-based studies.

What disciplines or areas of expertise are highlighted as important?

The opportunity explicitly calls for multidisciplinary work, highlighting novel device development, complex modeling of behaving human neural systems, clinical neurology, and animal research.

What does the opportunity mean by "complex modeling of behaving human neural systems"?

It suggests an emphasis on modeling and analytics that can handle complex human neural data collected during behavior or task performance, not only resting-state measurements.

Why does the program include animal research?

Animal research is included to explore mechanisms and validate approaches before or alongside translation, as part of the program’s broader translational pathway linking animal work, clinical neurology, and human device-based studies.

What is the ultimate end state DARPA signals for SUBNETS?

DARPA signals an end state that includes not only improved scientific understanding of brain-network dysfunction, but also progress toward safe and effective neurotechnological therapies that can be translated into human use.

What is the solicitation identifier for this opportunity?

This opportunity was issued as DARPA BAA 14-09.

Which DARPA office is associated with the program?

The program is associated with DARPA’s Defense Sciences Office.

What is the funding activity category?

The funding activity category is Science and Technology / Research and Development.

What CFDA number is associated with this opportunity?

The opportunity is associated with CFDA 12.910 (Research and Technology Development).

What award instruments were allowed under the solicitation?

The opportunity allowed for multiple award instruments, including cooperative agreements and other procurement contracts.

Is cost sharing or matching required?

No cost sharing or matching requirement was stated in the information provided.

Who was eligible to apply?

Eligibility was described as unrestricted, meaning any type of entity could apply, subject to any clarifications in the full announcement.

When was the solicitation posted?

The solicitation was posted on October 24, 2013.

What was the closing date?

The current closing date listed was April 22, 2014 (originally December 17, 2013).

When was the opportunity archived?

The archive date listed was June 23, 2014.

Who was the point of contact for access issues?

The listed point of contact for access issues was Dr. Justin Sanchez, BAA Coordinator.